BillionToOne Inc (BLLN)

Currency in USD
124.90
+10.48(+9.16%)
Closed·
123.50-1.40(-1.12%)
·
Advertisement
BLLN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
112.33127.72
52 wk Range
61.96150.44
Key Statistics
Prev. Close
114.42
Open
112.33
Day's Range
112.33-127.72
52 wk Range
61.96-150.44
Volume
997.15K
Average Volume (3m)
708.26K
1-Year Change
-
Book Value / Share
11.67
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BLLN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
119.75
Downside
-4.12%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

BillionToOne Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

7 Buy
2 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 119.75
(-4.12% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord
Buy120.00-3.92%-New Coverage02/09/2026
JPMorgan
Buy207.00+65.73%170.00Maintain06/08/2026
Guggenheim
Buy125.00+0.08%120.00Maintain29/06/2026
Guggenheim
Buy120.00-3.92%100.00Maintain13/05/2026
JPMorgan
Buy125.00+0.08%120.00Maintain07/05/2026

BillionToOne Inc Earnings Call Summary for Q2/2026

  • BillionToOne Q2 EPS hit $0.15, crushing $0.03 forecast; revenue surged 64% to $109.4M, but shares plunged 30% after-hours to $105.26.
  • Gross margin expanded to 70.5% from 65.3%; company swung to $8.1M net income vs. $0.2M loss year-ago, with $549M cash on hand.
  • Reiterated FY2026 revenue guidance of $450M-$465M (48-52% growth); expects sustained profitability amid commercial expansion investments.
  • Key growth drivers include 70-rep sales force expansion, Unity Confirm adoption, Epic Aura integration, and MolDX Medicare coverage expected by year-end.
  • Management flagged $10M in claims held pending payer in-network implementation; new oncology products may temporarily pressure margins near-term.
Last Updated: 05/08/2026, 22:40
Read Full Transcript

Earnings

Latest Release
05/08/2026
EPS / Forecast
0.15 / 0.03
Revenue / Forecast
109.4M / --
EPS Revisions
Last 90 days

Compare BLLN to Peers and Sector

Metrics to compare
BLLN
Peers
Sector
Relationship
P/E Ratio
177.6x0.1x−0.4x
PEG Ratio
1.38−0.770.00
Price/Book
11.0x6.2x2.6x
Price / LTM Sales
14.8x0.8x3.1x
Upside (Analyst Target)
−2.0%31.3%55.6%
Fair Value Upside
Unlock26.1%7.8%Unlock

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
6.61M14.00%756.10M
Other Institutional Investors
30.12M63.83%3.45B
Public Companies & Retail Investors
10.46M22.17%1.20B
Total
47.19M100.00%5.4B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Hummingbird Ventures Management NV16.71%7,887,187902,452
Libertus Capital Limited7.55%3,561,609407,519

People Also Watch

5.23
SION
-5.08%
60.77
ATRC
+1.36%
19.43
NAVN
-1.17%
22.41
TYRA
-3.53%

FAQ

What Is the BillionToOne (NASDAQ: BLLN) Share Price Today?

The BillionToOne stock price today is 124.90 USD.

What Stock Exchange Does BillionToOne (BLLN) Trade On?

BillionToOne is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for BillionToOne?

The stock symbol (also called a 'ticker') for BillionToOne is "BLLN."

What Is the Current BillionToOne Market Capitalisation?

As of today, BillionToOne (NASDAQ: BLLN) market cap is 5.40B USD.

What Is BillionToOne's (BLLN) Earnings Per Share (TTM)?

The BillionToOne EPS is currently 0.77 (Trailing Twelve Months).

When Is the Next BillionToOne Earnings Date?

BillionToOne's next earnings report will be released on 15/12/2026.

Is BLLN a Buy or Sell From a Technical Analyst Perspective?

Based on today's BillionToOne moving averages and other technical indicators, the daily buy/sell signal for BLLN stock is Strong Buy.

How Many Times Has BillionToOne Stock Split?

BillionToOne has split 0 times. (See the BLLN stock split history page for full effective split date and price information.)

How Many Employees Does BillionToOne Have?

BillionToOne has 713 employees, based on their latest Companies House report.

What is the current trading status of BillionToOne (NASDAQ: BLLN)?

As of 24/09/2026, BillionToOne (BLLN) is trading at a share price of 124.90 USD, with a previous close of 114.42 USD. The stock has fluctuated within a day range of 112.33 USD to 127.72 USD, while its 52-week range spans from 61.96 USD to 150.44 USD.

What Is BillionToOne (BLLN) Price Target According to Analysts?

The average 12-month price target for BillionToOne is 119.75 USD, with a high estimate of 145 USD and a low estimate of 90 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -4.12% Downside potential.

What Is the BLLN Premarket Price?

BLLN's last pre-market stock price is 112.50 USD. The pre-market share volume is 587.00, and the stock has decreased by -1.92, or -1.68%.

What Is the BLLN After Hours Price?

BLLN's last after hours stock price is 123.50 USD, the stock has decreased by -1.40, or -1.12%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.